Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-24 @ 10:53 PM
NCT ID:
NCT04937569
Eligibility Criteria:
Inclusion Criteria:
* Confirmed mild cases of COVID-19 defined as: symptomatic patients with any of COVID-19 symptoms (fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell),
* In addition to absolute leucopoenia (\< 4000) / absolute lymphopenia (\< 1000), positive CRP (C-reactive protein), high serum ferritin and/or positive PCR for SARS-CoV-2 in nasopharyngeal swab.
* no dyspnea and no abnormalities on high resolution chest imaging (HRCT).
* Patients should be at home (not admitted to hospital) with no supplemental oxygen treatment.
Exclusion Criteria:
* • Asymptomatic patients
* Dyspnoea or abnormalities on chest imaging
* Hospital admission
* Severe pneumonia
* Impairment in liver functions
* Received Ivermection in the last 5 days before being included in the study.
* Pregnancy is an exclusion criterion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04937569
Study Brief:
Protocol Section:
NCT04937569